Trending

Brilinta

New heart attack data boost AZ’s Brilinta

New heart attack data boost AZ’s Brilinta

A new sub-analysis of data from a phase 3 trial shows AstraZeneca’s Brilinta cuts the risk of cardiovascular death by 29% in high risk patients.

X

New heart attack data boost AZ’s Brilinta

https://pharmaphorum.com/news/new-heart-attack-data-boost-azs-brilinta/

AZ feels pain after heart drug fails again

AZ feels pain after heart drug fails again

Brilinta will not hit $3.5bn sales target, company admits.

X

AZ feels pain after heart drug fails again

https://pharmaphorum.com/news/az-feels-pain-heart-drug-fails/

Brilique boosted by NICE’s long-term prevention recommendation

Brilique boosted by NICE’s long-term prevention recommendation

Recommendation will add to growth trajectory

X

Brilique boosted by NICE’s long-term prevention recommendation

https://pharmaphorum.com/news/brilique-boosted-nices-long-term-prevention-recommendation/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com